Across TCGA pan-cancer cohorts, CYP4F30P Mutation is linked to patient survival in 1 of 34 cancer types, making it a survival-associated CYP4F30P data layer compared with 15 for mass-spec protein.

The strongest signal is observed in esophageal carcinoma (ESCA), where higher CYP4F30P Mutation is associated with worse overall survival. In most high-consensus cancer types, elevated CYP4F30P expression acts as an unfavorable survival marker.

ESCA are the cancer types where CYP4F30P Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
ESCA	OS	Median	II,III,IV	0.102	0.703	<.001	36	view →

Pink = unfavorable, green = favorable. Showing the 1 strongest of 1 lineages.

Exploration

Same gene, other analysis: CYP4F30P tumor-vs-normal RNA expression · all CYP4F30P data types